CNX-012 program
N/A
Report date: 2025/06/11 10:31:55
NME
Base Information
Drug NameCNX-012 program
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConnexios Life Sciences
China Registration ClassN/A
Develop Information
Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesConnexios Life Sciences
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A